|
Re: Sales could take a hit
|
3
|
Resverlogix Corp.
|
Apr 17, 2023 02:05PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
3
|
Resverlogix Corp.
|
Dec 05, 2019 07:42PM
|
|
Made for TV Movie
|
3
|
Resverlogix Corp.
|
Aug 28, 2017 08:02AM
|
|
Re: 5 million shares
|
3
|
Resverlogix Corp.
|
Sep 27, 2019 10:29AM
|
|
Re: Made for TV Movie
|
3
|
Resverlogix Corp.
|
Aug 28, 2017 08:45AM
|
|
Re: A Special Meeting of Shareholders?
|
3
|
Resverlogix Corp.
|
May 30, 2024 04:28PM
|
|
Zack's Research Report by Vandermosten dated Aug 2nd, 2017
|
3
|
Resverlogix Corp.
|
Aug 15, 2017 07:22AM
|
|
Re: Highest Volume days in last Five Years
|
3
|
Resverlogix Corp.
|
Apr 05, 2023 11:09AM
|
|
Re: Epizyme market cap $750 mil USd
|
3
|
Zenith Epigenetics
|
Jun 18, 2017 08:47AM
|
|
Re: Risk vs Reward moving forward!
|
3
|
Resverlogix Corp.
|
Dec 18, 2021 08:00AM
|
|
Re: Highest Volume days in last Five Years
|
3
|
Resverlogix Corp.
|
Apr 05, 2023 01:12PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
4
|
Resverlogix Corp.
|
Sep 14, 2017 08:02AM
|
|
Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
4
|
Resverlogix Corp.
|
Oct 04, 2023 08:44AM
|
|
RVX…The Hawthorne Effect
|
4
|
Resverlogix Corp.
|
Oct 01, 2022 11:18AM
|
|
Re: AGM attendance
|
4
|
Resverlogix Corp.
|
May 24, 2022 08:37PM
|
|
Re: Trials and statistics, next steps
|
4
|
Resverlogix Corp.
|
Feb 11, 2020 03:58PM
|
|
Re: Looks like 0 participation in warrant incentive imo - answer to my email...
|
4
|
Resverlogix Corp.
|
Jan 18, 2020 04:48PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
4
|
Resverlogix Corp.
|
Nov 14, 2022 06:49PM
|
|
Re: Forward looking statements...
|
4
|
Resverlogix Corp.
|
Feb 05, 2021 09:59AM
|
|
Re: https://themarkether...
|
4
|
Resverlogix Corp.
|
Mar 01, 2022 09:49PM
|
